Total Payments
$4,957
2024 Payments
$106.48
Companies
35
Transactions
488
Medicare Patients
331
Medicare Billing
$18,414
Payment Breakdown by Category
Food & Beverage$4,949 (99.8%)
Education$8.09 (0.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,949 | 486 | 99.8% |
| Education | $8.09 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $593.67 | 61 | $0 (2020) |
| SANOFI-AVENTIS U.S. LLC | $519.18 | 43 | $0 (2021) |
| PFIZER INC. | $501.90 | 114 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $419.97 | 10 | $0 (2024) |
| Novo Nordisk Inc | $406.70 | 28 | $0 (2024) |
| Lilly USA, LLC | $393.45 | 50 | $0 (2023) |
| Amgen Inc. | $332.97 | 25 | $0 (2023) |
| GlaxoSmithKline, LLC. | $303.55 | 38 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $290.70 | 20 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $209.50 | 16 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $106.48 | 7 | PFIZER INC. ($32.07) |
| 2023 | $186.77 | 12 | Amgen Inc. ($74.45) |
| 2022 | $505.28 | 36 | Lilly USA, LLC ($118.86) |
| 2021 | $601.48 | 50 | Lilly USA, LLC ($127.55) |
| 2020 | $391.44 | 22 | AstraZeneca Pharmaceuticals LP ($111.69) |
| 2019 | $670.19 | 92 | Allergan Inc. ($127.76) |
| 2018 | $1,265 | 140 | PFIZER INC. ($188.74) |
| 2017 | $1,230 | 129 | Allergan Inc. ($262.49) |
All Payment Transactions
488 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/18/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: VACCINES | ||||||
| 10/15/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.08 | General |
| Category: Respiratory | ||||||
| 10/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.62 | General |
| Category: Diabetes | ||||||
| 06/26/2024 | PFIZER INC. | PREMARIN (Drug), ESTRING, DUAVEE | Food and Beverage | In-kind items and services | $14.32 | General |
| Category: WOMENS HEALTH | ||||||
| 05/10/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: Respiratory | ||||||
| 02/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE, SYNJARDY | Food and Beverage | In-kind items and services | $14.43 | General |
| Category: DIABETES | ||||||
| 01/31/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: Diabetes | ||||||
| 12/20/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.06 | General |
| Category: Diabetes | ||||||
| 10/11/2023 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 09/27/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: Inflammation | ||||||
| 07/26/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: Inflammation | ||||||
| 06/20/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: Biological | ||||||
| 05/23/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: Inflammation | ||||||
| 05/17/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: Diabetes | ||||||
| 05/13/2023 | AbbVie Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $13.68 | General |
| Category: ANTI-INFECTIVE | ||||||
| 02/14/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: Inflammation | ||||||
| 02/07/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.65 | General |
| Category: Diabetes | ||||||
| 01/27/2023 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $12.70 | General |
| Category: Bone Health | ||||||
| 01/07/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: Diabetes | ||||||
| 12/17/2022 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: Diabetes | ||||||
| 12/13/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $24.77 | General |
| Category: PRIMARY CARE | ||||||
| 12/06/2022 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $9.48 | General |
| Category: Diabetes | ||||||
| 11/18/2022 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Seglentis | Food and Beverage | Cash or cash equivalent | $13.05 | General |
| Category: Cardiovascular | ||||||
| 11/12/2022 | Lilly USA, LLC | EMGALITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: Neuroscience | ||||||
| 10/11/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 127 | 150 | $26,772 | $12,346 |
| 2022 | 1 | 32 | 32 | $5,920 | $293.72 |
| 2021 | 5 | 79 | 96 | $11,354 | $3,086 |
| 2020 | 5 | 93 | 103 | $12,853 | $2,689 |
Total Patients
331
Total Services
381
Medicare Billing
$18,414
Procedure Codes
17
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 36 | 36 | $5,616 | $4,379 | 78.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 18 | 37 | $5,014 | $2,151 | 42.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 17 | 18 | $6,802 | $2,098 | 30.8% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 13 | 13 | $2,028 | $2,020 | 99.6% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 23 | 26 | $3,540 | $1,517 | 42.9% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Facility | 2023 | 20 | 20 | $3,772 | $180.40 | 4.8% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Facility | 2022 | 32 | 32 | $5,920 | $293.72 | 5.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 14 | 29 | $3,886 | $1,553 | 40.0% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 15 | 17 | $2,278 | $930.24 | 40.8% |
| 93016 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring and physician supervision | Facility | 2021 | 14 | 14 | $728.00 | $237.30 | 32.6% |
| 77080 | Bone density measurement of the core or central skeleton (e.g., hips, pelvis, spine) | Facility | 2021 | 22 | 22 | $4,070 | $206.58 | 5.1% |
| 93018 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician interpretation and report | Facility | 2021 | 14 | 14 | $392.00 | $159.18 | 40.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 15 | 22 | $2,948 | $1,121 | 38.0% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 17 | 20 | $2,680 | $846.28 | 31.6% |
| 77080 | Bone density measurement using dedicated x-ray machine | Office | 2020 | 33 | 33 | $6,105 | $319.81 | 5.2% |
| 93016 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring and physician supervision | Office | 2020 | 14 | 14 | $728.00 | $237.87 | 32.7% |
| 93018 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician interpretation and report | Office | 2020 | 14 | 14 | $392.00 | $164.18 | 41.9% |
About Dr. Christopher Tomhave, MD
Dr. Christopher Tomhave, MD is a Family Medicine healthcare provider based in Saint Paul, Nebraska. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/19/2005. The National Provider Identifier (NPI) number assigned to this provider is 1558347849.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Tomhave, MD has received a total of $4,957 in payments from pharmaceutical and medical device companies, with $106.48 received in 2024. These payments were reported across 488 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($4,949).
As a Medicare-enrolled provider, Tomhave has provided services to 331 Medicare beneficiaries, totaling 381 services with total Medicare billing of $18,414. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Saint Paul, NE
- Active Since 12/19/2005
- Last Updated 09/01/2020
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1558347849
Products in Payments
- FARXIGA (Drug) $289.57
- Ozempic (Drug) $246.28
- CHANTIX (Drug) $237.58
- TRULICITY (Drug) $209.46
- XARELTO (Drug) $206.83
- VRAYLAR (Drug) $177.95
- ENTRESTO (Drug) $168.95
- TOUJEO (Drug) $164.52
- TRADJENTA (Drug) $164.04
- LINZESS (Drug) $156.32
- TRELEGY ELLIPTA (Drug) $125.24
- SOLIQUA (Drug) $123.75
- SOLIQUA 100/33 (Biological) $123.59
- BYSTOLIC (Drug) $119.10
- ANORO (Drug) $117.39
- Aimovig (Biological) $94.43
- JARDIANCE (Drug) $92.79
- SYMBICORT (Drug) $90.56
- Otezla (Drug) $89.07
- TOVIAZ (Drug) $86.97
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Saint Paul
Dr. Amy Gilbert, Md, Mph, MD, MPH
Family Medicine — Payments: $74,414
Family Medicine $74,414
Dr. Deborah Wexler, Md, MD
Family Medicine — Payments: $15,853
Family Medicine $15,853
Dr. Angela Brennan, Md, MD
Family Medicine — Payments: $5,304
Family Medicine $5,304
Alana Sasaki, Md, MD
Family Medicine — Payments: $4,145
Family Medicine $4,145
Adam Rensch, M.d, M.D
Family Medicine — Payments: $4,061
Family Medicine $4,061
Dr. Kaitlin Hahn, M.d, M.D
Family Medicine — Payments: $2,632
Family Medicine $2,632